Several lysosomal enzymes present in human plasma (N-acetyl-ß-glucosaminidase, ß-glucuronidase, ß-galactosidase, -galactosidase, -L-fucosidase, -mannosidase, ß-glucosidase) were maintained in a fully active state for at least 8 months by the addition of ethylene glycol (300 g/1 final concentration) to freshly prepared plasma and storage at -20 °C.
Introduction

) Enzymes:
There is increasing evidence that lysosomal enzymes 2 )
N-Acetyl-ß-glucosaminidase: in blood serum or plasma have a diagnostic signifi-N-acetyl-ß-Z)-glucosaminide N-acetylglucosaminohydrolase cance not only for some of the rare syndromes derived ß-Galactosidase: from inborn lysosomal pathology (1) , but also for a ß-0-galactoside galactohydrolase EC 3.2.1.23 number of acquired diseases (2, 3) , including diabetes ß-Glucuronidase: (4, 5) . However, due mainly to methodological prob--Mannosidase: lems, lysosomal enzymes are not currently measured a-£>-mannoside mannohydrolase EC 3.2. in the clinical investigation of blood enzymes. Colorimetric and fluorimetric procedures for the assay of lysosomal enzymes in serum or plasma are actually available. They are reliable, and in the fluorimetric assays are also highly sensitive (6, 7) . However, all these methods are manual and not always easily adopted for routine analyses. Moreover, stable materials for calibration, and for running of intra-laboratory and inter-laboratory quality control programmes, are lacking.
The present work was undertaken with the aim of solving some of these difficulties.
The work was carried out on N-acetyl-ß-glucosaminidase, ß-glucuronidase, ß-galactosidase, -L-fucosidase, -mannosidase, -galactosidase, -glucosidase and ß-glucosidase, which are the lysosomal enzymes (glycohydrolases) with the highest diagnostic potential in acquired diseases. The isozymes A, B, l t and I 2 of N-acetyl-ß-glucosaminidase, known to be of diagnostic interest (8) , were also considered.
Materials and Methods
Chemicals
Commercial chemicals were of the highest purity available and water was freshly distilled in an all glass still before use. 4-Methylumbelliferone, purchased from Fluka GmbH (Buchs, Switzerland) was three times recrystallized from ethanol; 4-methylumbelliferyl-glycosides, to be used as substrates for the individual glycohydrolase, were purchased from Melford (Suffolk, U.K.), ethylene glycol, polyglycols and glycerol from Sigma Chem. Co. (St. Louis, Mo, USA), polybuffer exchanger PBE-94 and "polybufier 74"-HCl, pH 4.0 from Pharmacia Fine Chemicals (Uppsala, Sweden).
Blood sampling and preparation of plasma pools Plasma was prepared, under standard conditions, from blood treated with sodium citrate (final concentration, 11 mmol/1, which is known not to affect lysosomal enzymes activities (7)). Subjects were male and female healthy adults, aged 25 -55 years; most were volunteer blood donors, and all gave informed consent. Some were women in the final trimester of pregnancy which is characterized by a very high content of lysosomal enzymes in the plasma (9) . In all cases blood was withdrawn for control laboratory analyses, and the common blood analytes were within normal ranges.
Tab. Preparation of a stable liquid material for lysosomal enzyme assays Plasma specimens were divided into three pools: pool A, containing high lysosomal enzyme activities, obtained by pooling sera from pregnant women in the third trimester; pool B, containing medium lysosomal enzyme activities, obtained by pooling plasma from normal individuals; pool C, containing low levels of lysosomal enzyme activities, obtained by diluting pool B 1 : 2 (1 + 1, by vol.) with the same pool, which had been heat-treated (56 °C, 3 hours) to completely inactivate lysosomal enzymes.
Plasma pools A, B, C, were supplemented with several compounds (glycerol, ethylene glycol and a variety of polyglycols) known to stabilize enzymes or other analytes, carefully mixed by gentle stirring at 4 °C for 30 min, then divided into 1 ml glass ampules, tightly closed and stored at -20 °C.
Determination of lysosomal enzymes
The lysosomal enzymes were determined fluorimetrically by the manual optimized method previously described (7). Using plasma pool A, the isozymes of N-acetyl--glucosaminidase were separated and quantified by an automated method consisting of chromatofocusing on a polybuffer exchanger PBE-94 column, with flowthrough fluorimetric determination of activity and computer assisted quantification (10).
All enzyme activities were expressed as Units (U) per litre (1).
Statistical analysis
Regression analysis and Student's t test were calculated as described by Snedecor & Cochran (11) . The estimation of total imprecision by analysis of variance was performed according to the model of Krouwer, and NCCLS recommendations (12, 13) .
Results and Discussion
All lysosomal enzymes in serum or plasma are known to gradually loose their activity upon storage, even at -20 °C (7). In pilot experiments, several substances (glycerol, polyglycols, ethylene glycol), which behave as enzyme stabilizers, were added to plasma and the content of the lysosomal enzymes was monitored after storage at different temperatures and various periods of time. The most encouraging results were obtained by the addition of ethylene glycol (final concentration of 300 g/1) and storage of plasma at -20 °C. Ethylene glycol proved not to affect per se the assay method of any of the lysosomal enzymes studied. The activity values of the measured lysosomal enzymes in a pool of high enzyme content (pool A) after different periods (from 0 to 24 months) of storage at -20 °C are represented in figure 1 . The same figure also shows (e) up to 3 months for oc-glucosidase.
The same degree of stability of the analysed enzymes upon storage at -20 °C was observed for plasma pools B and C (tab. 1). The reason for the lower stability of -glucosidase during storage (matrix problems; necessity of special stabilizers, etc) is currently under investigation.
The analytical imprecision of the manual assays for plasma lysosomal enzymes (the isozymes of N-acetyl-ß-glucosaminidase were not included in this part of the study) was determined using the three plasma pools A, B, C over a period of two months, and expressed as the coefficient of variation. Ten replicate analyses were performed for each enzyme in ten different analytical series, covering a period of two months, according to the model of Krouwer, and NCCLS recommendations (12, 13) . The analytical imprecision for all the studied enzymes was higher in day-to-day than within-run determinations, and it decreased with increased enzyme catalytic concentration. In general, the analytical imprecision of the assay methods was acceptable (with a total coefficient of variation below 10%) for all determinations using plasma pool A, which contained the highest concentrations of lysosomal enzymes. An acceptable degree of imprecision was found with plasma pools B and C (intermediate and low enzyme levels) for the assay of N-acetyl-ß-glucosaminidase, -L-fucosidase, oc-galactosidase and -mannosidase. Coefficients of variation above 10% (and up to 18%) were shown by the assay of ß-glucuronidase (plasma pool C), ß-galactosidase, ß-glucosidase and -glucosidase (plasma pool B).
In conclusion, human plasma, supplemented with 300 g/1 ethylene glycol and stored at -20 °C, fulfils the requirements for a stable (for at least 8 months) liquid material suitable for calibration and quality control purposes in the plasma assay of several glycohydrolases of lysosomal origin.
